Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Veterinary Clinical Pathology|August 21, 2015
Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney diseaseJacqueline K Phillips, Rochelle Boyd, Mark B Krockenberger, et al.
Peerj|October 4, 2019
Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cellsShivani Sachdev, Rochelle Boyd, Natasha L Grimsey, et al.
Journal of Hypertension|July 18, 2018
Increased excitatory regulation of the hypothalamic paraventricular nucleus and circulating vasopressin results in the hypertension observed in polycystic kidney diseaseConor F Underwood, Rochelle Boyd, Jacqueline K Phillips, et al.
Frontiers in Physiology|June 5, 2015
Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney diseaseOmar Z Ameer, Rochelle Boyd, Mark Butlin, et al.
Transplantation|November 30, 2006
Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide productionNirupama D Verma, Rochelle Boyd, Catherine Robinson, et al.
ACS Chemical Neuroscience|August 10, 2017
Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their AnaloguesMitchell Longworth, Samuel D Banister, Rochelle Boyd, et al.
Clinical and Experimental Pharmacology & Physiology|February 14, 2015
Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney diseaseThamarasee M Jeewandara, Omar Z Ameer, Rochelle Boyd, et al.
Transplant Immunology|April 26, 2006
The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or toleranceMasaru Nomura, Karren M Plain, Nirupama Verma, et al.
Transplantation|April 7, 2007
Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administrationKarren M Plain, Rochelle Boyd, Nirupama D Verma, et al.
Frontiers in Pharmacology|June 14, 2019
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor AgonistRichard C Kevin, Lyndsey Anderson, Iain S McGregor, et al.
Pageof 4